ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS

Application Note Pharma & Biopharma Analysis of Artificial Tear Eye Drops For Elemental Impurities Using an ICP-MS and USP <232>/<233> and ICH Q3D(R2)/Q2(R1) protocols. Authors Jennifer Sanderson and Lindsey Whitecotton Agilent Technologies, Inc. Introduction As pharmaceutical products are released to…

Application Note Pharmaceuticals Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals Authors Lindsey Whitecotton, Ed McCurdy, Craig Jones…

Agilent ICP-MS Journal July 2017 – Issue 69 Inside this Issue 2-3 Automated Analysis of Environmental Samples using prepFAST-ICP-MS 4-5 ICP-MS for Elemental Impurities Analysis in Pharmaceuticals According to USP <232>/<233> and ICH Q3D 6 New! ICP-MS…

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis White paper Authors Amir Liba, Ed McCurdy and Ross Ashdown Agilent Technologies Abstract The United States Pharmacopeial Convention (USP), in parallel with…